Fig 3. Progression-free survival curves for CRC patients who received anti-EGFR treatment according to SMAD4 mutation status.
All patients were wild-type for KRAS, NRAS, and BRAF genes.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.